ResearcherUniversity of TorontoNo recent work listed

Stéphane Angers

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7241-9044; OpenAlex author ID A5040025979. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Amanda J. Boyle · 1 shared paper, 2023 · strength 0.22
- Paper Relative Biological Effectiveness (RBE) of [64Cu]Cu and [177Lu]Lu-NOTA-panitumumab F (ab')2 radioimmunotherapeutic agen… DOI 10.1016/j.nucmedbio.2023.108367 ↗
Raymond M. Reilly · 1 shared paper, 2023 · strength 0.22
- Paper Relative Biological Effectiveness (RBE) of [64Cu]Cu and [177Lu]Lu-NOTA-panitumumab F (ab')2 radioimmunotherapeutic agen… DOI 10.1016/j.nucmedbio.2023.108367 ↗
Traver Hart · 1 shared paper, 2016 · strength 0.05
- Paper A CRISPR screen reveals a WNT7B-FZD5 signaling circuit as a therapeutic opportunity in pancreatic cancer DOI 10.1101/041996 ↗
Jason Moffat · 1 shared paper, 2016 · strength 0.05
- Paper A CRISPR screen reveals a WNT7B-FZD5 signaling circuit as a therapeutic opportunity in pancreatic cancer DOI 10.1101/041996 ↗
Zachary Steinhart · 1 shared paper, 2016 · strength 0.05
- Paper A CRISPR screen reveals a WNT7B-FZD5 signaling circuit as a therapeutic opportunity in pancreatic cancer DOI 10.1101/041996 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.